Insiders Updates
NBIX’s latest rating updates from top analysts.
In a filing, Neurocrine Biosciences, Inc revealed its Director GORMAN KEVIN CHARLES unloaded Company’s shares for reported $13.44 million on
Menu
In a filing, Neurocrine Biosciences, Inc revealed its Director GORMAN KEVIN CHARLES unloaded Company’s shares for reported $13.44 million on
Neurocrine Biosciences, Inc’s recent filing unveils that its Director GORMAN KEVIN CHARLES unloaded Company’s shares for reported $13.44 million on
Neurocrine Biosciences, Inc’s recently made public that its Director GORMAN KEVIN CHARLES unloaded Company’s shares for reported $13.44 million on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Neurocrine Biosciences,
Neurocrine Biosciences, Inc’s filing revealed that its Director GORMAN KEVIN CHARLES unloaded Company’s shares for reported $13.44 million on Aug
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Neurocrine Biosciences, Inc revealed its Chief Regulatory Officer Delaet Ingrid unloaded Company’s shares for reported $61695.0 on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or